These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24133974)

  • 1. [Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy].
    Chen WG; Wang SB
    Yao Xue Xue Bao; 2013 Jul; 48(7):1091-8. PubMed ID: 24133974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress in co-delivery of gene and chemotherapy drugs with cationic liposome carrier for cancer therapy].
    Chen WG; Liu YG; Wang SB; Chen AZ
    Yao Xue Xue Bao; 2012 Aug; 47(8):986-92. PubMed ID: 23162893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantum rods as nanocarriers of gene therapy.
    Aalinkeel R; Nair B; Reynolds JL; Sykes DE; Law WC; Mahajan SD; Prasad PN; Schwartz SA
    Drug Deliv; 2012 May; 19(4):220-31. PubMed ID: 22643056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.
    Wei X; Song M; Li W; Huang J; Yang G; Wang Y
    Theranostics; 2021; 11(13):6334-6354. PubMed ID: 33995661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential.
    Larsson M; Huang WT; Liu DM; Losic D
    Cancer Treat Rev; 2017 Apr; 55():128-135. PubMed ID: 28363142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
    Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
    J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tailored DNA Nanoplatform for Synergistic RNAi-/Chemotherapy of Multidrug-Resistant Tumors.
    Liu J; Song L; Liu S; Zhao S; Jiang Q; Ding B
    Angew Chem Int Ed Engl; 2018 Nov; 57(47):15486-15490. PubMed ID: 30288887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
    Choudhury NN; He H
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons.
    Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B
    IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-combined nano-chemotherapeutics to tackle resistant tumors.
    Tekade RK; Tekade M; Kesharwani P; D'Emanuele A
    Drug Discov Today; 2016 Nov; 21(11):1761-1774. PubMed ID: 27380716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
    Jia HZ; Zhang W; Zhu JY; Yang B; Chen S; Chen G; Zhao YF; Feng J; Zhang XZ
    J Control Release; 2015 Oct; 216():9-17. PubMed ID: 26272764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
    Chen H; Zhao Y; Wang H; Nie G; Nan K
    Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells.
    Chen CK; Law WC; Aalinkeel R; Yu Y; Nair B; Wu J; Mahajan S; Reynolds JL; Li Y; Lai CK; Tzanakakis ES; Schwartz SA; Prasad PN; Cheng C
    Nanoscale; 2014; 6(3):1567-72. PubMed ID: 24326457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine to overcome cancer multidrug resistance.
    Yang X; Yi C; Luo N; Gong C
    Curr Drug Metab; 2014; 15(6):632-49. PubMed ID: 25255871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmable Tetrahedral DNA-RNA Nanocages Woven with Stimuli-Responsive siRNA for Enhancing Therapeutic Efficacy of Multidrug-Resistant Tumors.
    Chen C; Yu M; Li Q; Zhou Y; Zhang M; Cai S; Yu J; Huang Z; Liu J; Kuang Y; Tang X; Chen W
    Adv Sci (Weinh); 2024 Aug; 11(32):e2404112. PubMed ID: 38923806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
    Babu A; Munshi A; Ramesh R
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in nanomedicine for enhanced cancer chemotherapy.
    Wei G; Wang Y; Yang G; Wang Y; Ju R
    Theranostics; 2021; 11(13):6370-6392. PubMed ID: 33995663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.